US2012291789A1PendingUtilityA1
Medical composition for protuberance of epithelium
Est. expiryNov 5, 2021(expired)· nominal 20-yr term from priority
A61K 31/728A61K 31/726A61P 41/00
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A medical composition for protuberance of epithelium, which comprises a solution comprising a polysaccharide or a medically acceptable salt thereof, wherein the solution has a viscosity of: (1) from 50 to 500 mPa·s at a shear rate of from 7.7 to 10.0 s −1 ; (2) from 45 to 300 mPa·s at a shear rate of from 19.2 to 20.0 s −1 ; and (3) from 40 to 200 mPa·s at a shear rate of from 38.3 to 40.0 s −1 , when measured using a rotational viscometer at 25° C., and a syringe filled with the medical composition.
Claims
exact text as granted — not AI-modified1 - 16 . (canceled)
17 . A method for resecting epithelium, which comprises:
administering an effective amount of a medical composition to under epithelium to thereby obtain protuberance of the epithelium; and resecting the protuberance, wherein the medical composition comprises a solution comprising sodium hyaluronate having a weight average molecular weight of from 880,000 to 920,000 and its concentration in the solution is 0.4% (w/v).
18 . The method according to claim 17 , wherein the epithelium is mucosa.
19 . The method according to claim 18 , wherein the mucosa is digestive organ mucosa.
20 . The method according to claim 17 , which is used for a mucosal resection.
21 . The method according to claim 17 , wherein the composition is administered using a syringe.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.